MGA:NYSEMagna International, Inc. Analysis
Data as of 2026-05-22 - not real-time
$64.10
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Magna International (MGA) is trading at $64.1, comfortably above its 20‑day SMA of $61.76 and 50‑day SMA of $58.77, indicating short‑term bullish momentum, while still below the 200‑day SMA of $52.86, confirming a longer‑term uptrend. Technical signals are mixed: RSI sits at 59.9 (neutral), MACD histogram is slightly negative and flagged as bearish, and volume is on a decreasing trend, suggesting caution on immediate upside. The stock’s beta of 1.23 and 30‑day volatility of 38.9% point to higher price swings typical of the consumer‑cyclical auto‑parts sector. Fundamentally, MGA appears undervalued with a DCF fair value of $94.45, offering roughly a 7% upside, while the forward PE of 8.43 and forward EPS of $7.60 signal strong earnings growth ahead. Recent earnings have delivered a 58% YoY jump in adjusted EBIT and a 190‑bp margin expansion to 5.4%, reinforcing the earnings momentum highlighted in the latest news. The dividend yield of 3.14% is attractive, but an 82% payout ratio raises sustainability questions given a debt‑to‑equity of 54.6% and modest ROE of 5.97%. Overall, the combination of bullish price positioning, earnings beat expectations, and an attractive valuation makes MGA a compelling near‑term buy, while its cyclicality and leverage suggest a more measured stance for the longer horizon.
The upcoming Q1 earnings release, where consensus EPS is expected to rise 29.5% YoY, could serve as a catalyst, especially if the company continues to beat revenue and earnings estimates as it has 75% and 50% of the time respectively. Investors should weigh the upside from undervaluation and dividend income against the higher volatility, leverage, and sector‑specific risks before deciding on position sizing.
The upcoming Q1 earnings release, where consensus EPS is expected to rise 29.5% YoY, could serve as a catalyst, especially if the company continues to beat revenue and earnings estimates as it has 75% and 50% of the time respectively. Investors should weigh the upside from undervaluation and dividend income against the higher volatility, leverage, and sector‑specific risks before deciding on position sizing.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 8/10
Key Factors
- Price above 20‑day and 50‑day SMAs indicating bullish momentum
- Upcoming earnings expected to beat consensus estimates
- Attractive dividend yield despite high payout ratio
Medium Term
1–3 yearsPositive
Model confidence: 9/10
Key Factors
- Undervalued relative to DCF fair value with ~7% upside
- Strong forward earnings growth (forward PE 8.43, forward EPS $7.60)
- Margin expansion and robust cash flow supporting operations
Long Term
> 3 yearsNeutral
Model confidence: 7/10
Key Factors
- Cyclical exposure to the auto‑parts sector and high beta
- Elevated debt levels and moderate ROE limiting upside
- Sustainable dividend income balanced against payout sustainability
Key Metrics & Analysis
Financial Health
Revenue Growth3.10%
Profit Margin1.58%
P/E Ratio27.0
ROE5.97%
ROA4.41%
Debt/Equity54.60
P/B Ratio1.5
Op. Cash Flow$4.2B
Free Cash Flow$2.1B
Technical Analysis
TrendBullish
RSI59.9
Support$57.48
Resistance$64.62
MA 20$61.76
MA 50$58.77
MA 200$52.86
MACDBearish
VolumeDecreasing
Fear & Greed Index91.79
Valuation
Fair Value$94.45
Target Price$68.61
Upside/Downside7.04%
GradeUndervalued
TypeBlend
Dividend Yield3.14%
Risk Assessment
Beta1.23
Volatility38.91%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.